The impact of survivin on prognosis and clinicopathology of glioma patients: a systematic meta-analysis (Q48636498)

13 February 2018

meta-analysis

0 references

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

The impact of survivin on prognosis and clinicopathology of glioma patients: a systematic meta-analysis (English)

1 reference

13 February 2018

author name string

Shunzeng Lv

1

1 reference

13 February 2018

Congxin Dai

2

1 reference

13 February 2018

Yuting Liu

3

1 reference

13 February 2018

Ranran Shi

4

1 reference

13 February 2018

Zhenyu Tang

5

1 reference

13 February 2018

Mingzhi Han

6

1 reference

13 February 2018

Ruixiang Bian

7

1 reference

13 February 2018

Bowen Sun

8

1 reference

13 February 2018

Renzhi Wang

9

1 reference

13 February 2018

publication date

27 July 2014

1 reference

13 February 2018

published in

Molecular Neurobiology

1 reference

13 February 2018

volume

51

1 reference

13 February 2018

issue

3

1 reference

13 February 2018

page(s)

1462-1467

1 reference

13 February 2018

Focus on central nervous system neoplasia

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8823-5

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8823-5

Nuclear survivin as a biomarker for non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8823-5

Prognostic importance of survivin in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8823-5

Survivin expression and its relation with proliferation, apoptosis, and angiogenesis in brain gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8823-5

Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8823-5

No prognostic impact of survivin expression in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8823-5

Survivin subcellular localization in high-grade astrocytomas: simultaneous expression in both nucleus and cytoplasm is negative prognostic marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8823-5

Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8823-5

Practical methods for incorporating summary time-to-event data into meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8823-5

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8823-5

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8823-5

Quantitatively determined survivin expression levels are of prognostic value in human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8823-5

Expression of cytoplasmic and nuclear Survivin in primary and secondary human glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8823-5

[Nuclear expression of Survivin in glioma and its correlation to prognosis]

21 January 2018

1 reference

12 December 2020

Knockdown of survivin expression by small interfering RNA suppresses proliferation of two human cancer cell lines

1 reference

12 December 2020

IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs

1 reference

12 December 2020

[Nuclear and cytoplasmic expressions of survivin in glioma and their prognostic value].

1 reference

12 December 2020

Nuclear survivin expression predicts poorer prognosis in glioblastoma

1 reference

12 December 2020

Prognosis of glioma patients by combined immunostaining for survivin, Ki-67 and epidermal growth factor receptor

1 reference

12 December 2020

Survivin gene expression in chronic liver disease and hepatocellular carcinoma.

1 reference

12 December 2020

Publication bias and dissemination of clinical research.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1007/S12035-014-8823-5

Identifiers

DOI

10.1007/S12035-014-8823-5

1 reference

13 February 2018

1 reference

13 February 2018